Neal James R
Insider CIK 1600865 · PALI Director · PCSA Director · AKTX Director · PKBO Director · XOMA VP Business Development, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 62,221 | — | $0 | 67,470 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 62,221 | — | $0 | 67,470 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-06-26 | 2026-06-30 | 203 | — | $0 | 5,249 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-06-26 | 2026-06-30 | 203 | — | $0 | 1,021 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-02 | 789 | $2.54 | $2.0K | 818 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2026-03-16 | 2,473 | $0.40 | $989 | 2,473 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2026-03-16 | 2,473 | — | $0 | 2,473 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2026-03-16 | 3,093 | $0.40 | $1.2K | 3,093 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2026-03-16 | 3,093 | — | $0 | 3,093 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-07-24 | 2025-07-28 | 175,299 | — | $0 | 206,505 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 4,464 | $1.12 | $5.0K | 4,464 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 4,464 | $1.12 | $5.0K | 4,464 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 4,464 | $1.12 | $5.0K | 36,271 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-01-09 | 2025-01-10 | 8,000,000 | — | $0 | 32,216,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-23 | 2024-12-26 | 2,000,000 | — | $0 | 24,216,000 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer deriv | 2024-11-14 | 2024-11-18 | 500,000 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion deriv | 2024-11-14 | 2024-11-18 | 33,340 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer deriv | 2024-11-14 | 2024-11-18 | 0 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 37,850 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion | 2024-11-14 | 2024-11-18 | 37,850 | — | $0 | 37,850 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-09-03 | 2025-09-18 | 31,206 | — | $0 | 36,275 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-09-03 | 2024-09-18 | 31,206 | — | $0 | 31,206 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 6,880 | — | $0 | 0 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 12,160 | — | $0 | 0 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 5,820 | — | $0 | 0 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 5,100 | — | $0 | 0 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise deriv | 2024-02-09 | 2024-02-13 | 6,880 | — | $0 | 6,880 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise | 2024-02-09 | 2024-02-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| PALI PALISADE BIO, INC. | M Exercise | 2024-02-09 | 2024-02-13 | 5,820 | — | $0 | 10,920 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-06-27 | 2023-07-24 | 101,365 | — | $0 | 101,365 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2023-06-27 | 2023-07-24 | 14,407 | — | $0 | 0 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2023-06-27 | 2023-07-24 | 14,407 | — | $0 | 14,407 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| PKBO Peak Bio, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 0 | $20004.00 | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 33,340 | — | $0 | 33,340 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-07-19 | 2022-07-21 | 17,797 | — | $0 | 17,797 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2022-07-15 | 2022-07-18 | 25,000 | — | $0 | 218,056 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-07-15 | 2022-07-18 | 905 | $31.86 | $28.8K | 11,822 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-07-15 | 2022-07-18 | 3,212 | $31.19 | $100.2K | 12,727 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2022-07-15 | 2022-07-18 | 25,000 | $4.03 | $100.8K | 36,822 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-07-15 | 2022-07-18 | 20,883 | $29.55 | $617.1K | 15,939 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2022-03-23 | 2022-03-23 | 1,111 | — | $0 | 102,800 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2022-03-23 | 2022-03-23 | 1,111 | $4.03 | $4.5K | 12,933 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-03-23 | 2022-03-23 | 1,111 | $30.02 | $33.4K | 11,822 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2022-03-22 | 2022-03-23 | 2,339 | — | $0 | 103,911 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-03-22 | 2022-03-23 | 2,339 | $30.02 | $70.2K | 11,822 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2022-03-22 | 2022-03-23 | 2,339 | $4.03 | $9.4K | 14,161 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2022-03-21 | 2022-03-23 | 50,000 | — | $0 | 106,250 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2022-03-21 | 2022-03-23 | 50,000 | $4.03 | $201.5K | 61,822 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2022-03-21 | 2022-03-23 | 50,000 | $29.01 | $1.45M | 11,822 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2021-12-21 | 2021-12-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2021-06-25 | 2021-06-29 | 686 | $35.13 | $24.1K | 11,822 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2021-06-25 | 2021-06-29 | 7,170 | $33.36 | $239.2K | 13,679 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2021-06-25 | 2021-06-29 | 1,171 | $34.30 | $40.2K | 12,508 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 4,406 | — | $0 | 4,406 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 5,091 | — | $0 | 5,091 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 3,398 | — | $0 | 3,398 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 849 | — | $0 | 849 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 1,359 | — | $0 | 1,359 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-04-27 | 2021-04-29 | 1,298 | — | $0 | 1,298 | SEC↗ |
| XOMA XOMA Corp | A Award | 2021-04-09 | 2021-04-13 | 8,000 | $25.00 | $200.0K | 8,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2021-02-17 | 2021-02-19 | 60,268 | — | $0 | 60,268 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2020-12-15 | 2020-12-17 | 26,000 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-12-15 | 2020-12-17 | 20,294 | $41.15 | $835.1K | 26,555 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2020-12-15 | 2020-12-17 | 26,000 | $5.50 | $143.0K | 46,849 | SEC↗ |
| XOMA XOMA Corp | A Award | 2020-12-15 | 2020-12-17 | 8,000 | $25.00 | $200.0K | 8,000 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-12-15 | 2020-12-17 | 5,706 | $42.04 | $239.9K | 20,849 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2020-11-23 | 2020-11-24 | 13,126 | — | $0 | 26,000 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2020-11-23 | 2020-11-24 | 13,126 | $5.50 | $72.2K | 33,975 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-11-23 | 2020-11-24 | 13,126 | $32.96 | $432.6K | 20,849 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2020-11-20 | 2020-11-24 | 6,874 | — | $0 | 39,126 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-11-20 | 2020-11-24 | 6,448 | $32.46 | $209.3K | 21,275 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-11-20 | 2020-11-24 | 426 | $33.35 | $14.2K | 20,849 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2020-11-20 | 2020-11-24 | 6,874 | $5.50 | $37.8K | 27,723 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2020-11-05 | 2020-11-06 | 10,000 | — | $0 | 46,000 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-11-05 | 2020-11-06 | 727 | $27.50 | $20.0K | 20,849 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2020-11-05 | 2020-11-06 | 10,000 | $5.50 | $55.0K | 30,849 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2020-11-05 | 2020-11-06 | 9,273 | $25.90 | $240.2K | 21,576 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2020-03-23 | 2020-03-24 | 1,000 | $14.50 | $14.5K | 20,849 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2020-03-20 | 2020-03-23 | 1,000 | $16.41 | $16.4K | 19,849 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2020-03-13 | 2020-03-16 | 66,200 | — | $0 | 66,200 | SEC↗ |
| XOMA XOMA Corp | X Exercise deriv | 2019-12-23 | 2020-01-16 | 1,180 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Corp | X Exercise | 2019-12-23 | 2020-01-16 | 1,180 | $22.00 | $26.0K | 18,849 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2019-11-06 | 2019-11-08 | 4,348 | — | $0 | 56,000 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2019-11-06 | 2019-11-08 | 4,348 | $22.00 | $95.7K | 17,669 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2019-11-06 | 2019-11-08 | 4,348 | $5.50 | $23.9K | 22,017 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2019-09-20 | 2019-09-20 | 5,452 | — | $0 | 60,348 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2019-09-20 | 2019-09-20 | 5,452 | $5.50 | $30.0K | 23,121 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2019-09-20 | 2019-09-20 | 5,452 | $20.23 | $110.3K | 17,669 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2019-09-19 | 2019-09-20 | 6,370 | — | $0 | 65,800 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2019-09-19 | 2019-09-20 | 3,728 | $20.69 | $77.1K | 20,311 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2019-09-19 | 2019-09-20 | 2,642 | $21.73 | $57.4K | 17,669 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2019-09-19 | 2019-09-20 | 6,370 | $5.50 | $35.0K | 24,039 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2019-09-18 | 2019-09-20 | 3,830 | — | $0 | 72,170 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2019-09-18 | 2019-09-20 | 3,830 | $5.50 | $21.1K | 21,499 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2019-09-18 | 2019-09-20 | 3,830 | $21.96 | $84.1K | 17,669 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2019-02-13 | 2019-02-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| XOMA XOMA Corp | X Exercise deriv | 2018-12-20 | 2018-12-21 | 678 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Corp | X Exercise | 2018-12-20 | 2018-12-21 | 678 | $13.00 | $8.8K | 21,011 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2018-11-13 | 2018-11-15 | 4,000 | $13.26 | $53.0K | 20,333 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2018-04-27 | 2018-04-27 | 15,655 | — | $0 | 76,000 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2018-04-27 | 2018-04-27 | 15,655 | $5.50 | $86.1K | 31,988 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2018-04-27 | 2018-04-27 | 15,655 | $24.42 | $382.3K | 16,333 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2018-04-26 | 2018-04-27 | 8,345 | — | $0 | 91,655 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2018-04-26 | 2018-04-27 | 8,345 | $5.50 | $45.9K | 24,678 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2018-04-26 | 2018-04-27 | 8,345 | $24.69 | $206.0K | 16,333 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2018-02-14 | 2018-02-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2017-11-15 | 2017-11-15 | 26,145 | — | $0 | 266,204 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-15 | 2017-11-15 | 2,200 | $27.44 | $60.4K | 16,333 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-15 | 2017-11-15 | 23,945 | $27.00 | $646.5K | 18,533 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2017-11-15 | 2017-11-15 | 26,145 | $4.03 | $105.4K | 42,478 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2017-11-14 | 2017-11-15 | 8,583 | — | $0 | 292,349 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-14 | 2017-11-15 | 600 | $30.45 | $18.3K | 16,333 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-14 | 2017-11-15 | 900 | $29.42 | $26.5K | 16,933 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-14 | 2017-11-15 | 3,564 | $29.05 | $103.5K | 17,833 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2017-11-14 | 2017-11-15 | 8,583 | $4.03 | $34.6K | 24,916 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-14 | 2017-11-15 | 3,519 | $27.13 | $95.5K | 21,397 | SEC↗ |
| XOMA XOMA Corp | M Exercise deriv | 2017-11-13 | 2017-11-15 | 11,568 | — | $0 | 300,932 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-13 | 2017-11-15 | 484 | $31.77 | $15.4K | 16,333 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-11-13 | 2017-11-15 | 11,084 | $30.79 | $341.3K | 16,817 | SEC↗ |
| XOMA XOMA Corp | M Exercise | 2017-11-13 | 2017-11-15 | 11,568 | $4.03 | $46.6K | 27,901 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-03-21 | 2017-03-23 | 5,105 | $5.40 | $27.6K | 15,366 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2017-02-10 | 2017-05-22 | 312,500 | — | $0 | 312,500 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-02-01 | 2017-02-01 | 95 | $4.50 | $428 | 20,471 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-02-01 | 2017-02-01 | 100 | $4.53 | $453 | 20,566 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2017-01-09 | 2017-01-10 | 125 | $5.15 | $644 | 20,666 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2016-12-22 | 2016-12-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2016-11-01 | 2016-11-03 | 150 | $5.25 | $788 | 20,541 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2016-10-07 | 2016-10-11 | 2,500 | $0.45 | $1.1K | 413,839 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2016-03-22 | 2016-03-22 | 19,813 | $0.78 | $15.5K | 411,339 | SEC↗ |
| XOMA XOMA Corp | A Award | 2016-02-25 | 2016-02-29 | 248,954 | — | $0 | 431,152 | SEC↗ |
| XOMA XOMA Corp | D To issuer | 2015-08-14 | 2015-08-18 | 9,067 | $0.83 | $7.5K | 175,402 | SEC↗ |
| XOMA XOMA Corp | D To issuer | 2015-03-18 | 2015-03-20 | 5,498 | $4.01 | $22.0K | 184,469 | SEC↗ |
| XOMA XOMA Corp | D To issuer | 2015-03-18 | 2015-03-20 | 3,521 | $4.01 | $14.1K | 189,967 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2015-02-26 | 2015-03-02 | 72,500 | $3.83 | $277.7K | 72,500 | SEC↗ |
| XOMA XOMA Corp | A Award | 2015-02-26 | 2015-03-02 | 52,500 | — | $0 | 193,488 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2014-11-26 | 2014-12-01 | 1,678 | $5.67 | $9.5K | 137,760 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2014-11-24 | 2014-11-24 | 1,032 | $5.03 | $5.2K | 139,438 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2014-11-13 | 2014-11-17 | 4,387 | $3.89 | $17.1K | 140,470 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2014-08-15 | 2014-08-18 | 6,584 | $4.61 | $30.4K | 144,857 | SEC↗ |
| XOMA XOMA Corp | S Sale | 2014-03-18 | 2014-03-20 | 2,671 | $6.32 | $16.9K | 151,441 | SEC↗ |